| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/18/2011 | CA2310534C Methods and compositions for treating primary and secondary tumors of the central nervous system (cns) |
| 01/18/2011 | CA2260266C Purified compositions of 10-propargyl-10-deazaaminopterin and methods of using same in the treatment of tumors |
| 01/18/2011 | CA2189055C Methods for modulating t cell responses by manipulating intracellular signal transduction |
| 01/16/2011 | CA2685842A1 A method for the treatment of cancer |
| 01/13/2011 | WO2011006084A2 Vaccines with oncofetal antigen/ilrp-loaded autologous dendritic cells and uses thereof |
| 01/13/2011 | WO2011005886A1 Method of reducing multi-drug resistance using inositol tripyrophosphate |
| 01/13/2011 | WO2011005832A1 Stable crystalline polymorphs of the dipotassium salt of (s) -2- {4- [2- (2, 4-diamin0-quinaz0lin-6-yl) -ethyl] -benzoylamino} -4-methylenξ-penta nedioic acid |
| 01/13/2011 | WO2011005714A2 Bendamustine liposomal compositions |
| 01/13/2011 | WO2011005525A2 Prodrug anti-cancer therapy |
| 01/13/2011 | WO2011005515A2 Bis-trifluoromethyl honokiol analogs and their use in treating cancers |
| 01/13/2011 | WO2011005473A2 Methods for treating or preventing fatigue |
| 01/13/2011 | WO2011005380A2 Arg-gly-asp-conjugated alpha-melanocyte stimulating hormone hybrid peptide for use in diagnosing and treating melanoma, including metastatic melanoma and methods related to same |
| 01/13/2011 | WO2011005377A2 Compositions and methods comprising vegfr-2 and vegfr-3 antagonists for the treatment of metastatic disease |
| 01/13/2011 | WO2011005219A1 Novel mdm2 binding peptides and uses thereof |
| 01/13/2011 | WO2011004899A1 Cancerous disease modifying antibodies |
| 01/13/2011 | WO2011004837A1 Antibody having anti-cancer activity |
| 01/13/2011 | WO2011004610A1 Azabicyclo compound and salt thereof |
| 01/13/2011 | WO2011004379A1 Compositions and methods for treating cancer |
| 01/13/2011 | WO2011004201A1 Preserved compositions of activated nk cells and methods of using the same |
| 01/13/2011 | WO2011004196A1 Cyclic triazo sodium channel blockers |
| 01/13/2011 | WO2011004166A1 Combined preparation for use as a medicament |
| 01/13/2011 | WO2011004132A1 Novel hsp90-inhibiting indole derivatives, compositions containing said derivatives, and use thereof |
| 01/13/2011 | WO2011003999A1 Metallic nanoparticles, preparation and uses thereof |
| 01/13/2011 | WO2011003886A1 Pegylated l-asparaginase |
| 01/13/2011 | WO2011003633A1 Pegylated l-asparaginase |
| 01/13/2011 | WO2011003626A1 INDUCTION OF α-HELIX CONFORMATIONS IN PROTEINS AND PEPTIDES |
| 01/13/2011 | WO2011003604A1 Indazolyl-substituted dihydroisoxa-zolopyridines and methods of use thereof |
| 01/13/2011 | WO2011003418A1 Heterocyclic compounds as jak receptor and protein tyrosine kinase inhibitors |
| 01/13/2011 | WO2011003369A1 New tumor marker |
| 01/13/2011 | WO2011003365A1 Histone deacetylase inhibitors with branched structure synthesized through click chemistry |
| 01/13/2011 | WO2011003362A1 Salts of 13a-(s)desoxytylophorinine, preparation methods and pharmaceutical compositions and uses thereof |
| 01/13/2011 | WO2011003237A1 Use of two microrna moleculars in lung caner prognosis and medicine preparation |
| 01/13/2011 | WO2011003194A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2010138839A9 Use of 2 anti-sparc antibodies to predict response to chemotherapy |
| 01/13/2011 | WO2010135170A3 Nitrile derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | WO2010133941A3 New hybrid particles and their use in diagnostics and therapy |
| 01/13/2011 | WO2010132547A3 Oxaza heterocyclic compounds for phototherapy |
| 01/13/2011 | WO2010132047A8 Guanosine/gmp gels and uses thereof |
| 01/13/2011 | WO2010118309A3 Inhibitors of stat3 and uses thereof |
| 01/13/2011 | WO2010110993A3 Methods and compositions for the treatment of cancer |
| 01/13/2011 | WO2010104691A3 Estrogenic compounds and their methods of use |
| 01/13/2011 | WO2010102277A3 Methods of diagnosing and treating prostate cancer characterized by ndrg1-erg fusion |
| 01/13/2011 | WO2010102095A3 Kinase protein binding inhibitors |
| 01/13/2011 | WO2010101964A3 Methods and compositions useful in treating cancer and reducing wnt mediated effects in a cell |
| 01/13/2011 | WO2010101888A3 Methods and compositions for treatment of tumor metastasis |
| 01/13/2011 | WO2010096466A9 Methods and compositions for inhibiting cellular proliferation and surgical adhesion |
| 01/13/2011 | WO2010077894A3 Methods of inhibiting quiescent tumor proliferation |
| 01/13/2011 | US20110009955 Compounds and method for coating surfaces in a hemocompatible manner |
| 01/13/2011 | US20110009625 Novel compounds |
| 01/13/2011 | US20110009495 Inhibition of the Survival of Bone Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/13/2011 | US20110009494 Inhibition of the Survival of Pancreatic Cancer by Cyclohexenone Compounds from Antrodia Camphorata |
| 01/13/2011 | US20110009483 Acyloxyalkyl carbamate prodrugs of tranexamic acid, methods of synthesis and use |
| 01/13/2011 | US20110009481 Medicament for the treatment of viral skin and tumour diseases |
| 01/13/2011 | US20110009480 Biologically active taxane analogs and methods of treatment |
| 01/13/2011 | US20110009474 Sirtuin based methods and compositions for treating beta-catenin-related conditions |
| 01/13/2011 | US20110009473 Pttg1 as a biomarker for cancer treatment |
| 01/13/2011 | US20110009472 RNAi Probes Targeting Cancer-Related Proteins |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009469 Compositions and methods of treating neoplasia |
| 01/13/2011 | US20110009468 Mirna, sirna and use thereof in therapy |
| 01/13/2011 | US20110009464 Immune system stimulation by light therapy induced apoptotic cell death in abnormal tissue |
| 01/13/2011 | US20110009463 Geranylgeranyl transferase inhibitors and methods of making and using the same |
| 01/13/2011 | US20110009459 Epothilone derivatives |
| 01/13/2011 | US20110009458 Stable formulations of thiadiazole derivative |
| 01/13/2011 | US20110009452 Hydroxyalkanyl amides as modulators of chemokine receptor activity |
| 01/13/2011 | US20110009450 Crystalline form of benzothiophene compound and process for preparation thereof |
| 01/13/2011 | US20110009448 Compound |
| 01/13/2011 | US20110009447 Substituted Benzoic Acid Amides and Use thereof for the Inhibition of Angiogenesis |
| 01/13/2011 | US20110009442 Methods for stereoselective reduction |
| 01/13/2011 | US20110009435 Hetero bicyclic carboxamide derivatives and their pharmaceutical use and compositions |
| 01/13/2011 | US20110009434 Crystals of isopropyl ester of n-(2,6-dichlorobenzoyl)-4-[6-(methylamino)methyl -1-methyl-2,4-dioxo-1,4-dihydroquinazoline-3(2h)-yl]-l- phenylalanine hydrochloride, production method thereof and use thereof |
| 01/13/2011 | US20110009432 Pyrid-2yl fused heterocyclic compounds, and compositions and uses thereof |
| 01/13/2011 | US20110009426 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin ii receptor antagonists |
| 01/13/2011 | US20110009415 Thienopyridazine Compounds, Their Preparations, Pharmaceutical Compositions And Uses |
| 01/13/2011 | US20110009412 Macrophage migration inhibitory factor antagonists and methods of using same |
| 01/13/2011 | US20110009405 Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy |
| 01/13/2011 | US20110009404 4-aryl-2-anilino-pyrimidines |
| 01/13/2011 | US20110009403 2-morpholinylpurines as inhibitors of pi3k |
| 01/13/2011 | US20110009400 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009396 Tricyclic compounds for the treatment of inflammatory disorders |
| 01/13/2011 | US20110009393 Novel Soluble 1,4 Benzodiazepine Compounds and Stable Salts Thereof |
| 01/13/2011 | US20110009388 Formulations and Methods of Administration of Cephalotaxines, Including Homoharringtonine |
| 01/13/2011 | US20110009387 Histone h2ax (hh2ax) biomarker for fti sensitivity |
| 01/13/2011 | US20110009383 Method of treating mixed lineage leukemia gene-rearranged acute lymphoblastic leukemias |
| 01/13/2011 | US20110009377 Azetidine derivatives, their preparation and their application in therapy |
| 01/13/2011 | US20110009373 Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis |
| 01/13/2011 | US20110009365 Derivatives of indole-2-carboxamides and of azaindole-2-carboxamides substituted with a silanyl group, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009364 Azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 01/13/2011 | US20110009363 Synthesis and biological activities of new tricyclic-bis-enones (tbes) |
| 01/13/2011 | US20110009361 Design and selection of medicaments that modulate the function and activity of interleukin 13 |
| 01/13/2011 | US20110009356 Novel phosphorus-containing prodrugs |
| 01/13/2011 | US20110009353 Targeting cdk4 and cdk6 in cancer therapy |
| 01/13/2011 | US20110009342 Uses of pdcd5 polypeptide for tumor chemotherapy and organ protection |
| 01/13/2011 | US20110009338 Controlled release formulations of octreotide |
| 01/13/2011 | US20110009337 Q3 sparc deletion mutant and uses thereof |
| 01/13/2011 | US20110009336 Treatment of Cancers with Immunostimulatory HIV TAT Derivative Polypeptides |
| 01/13/2011 | US20110009335 Anticancer Treatments |
| 01/13/2011 | US20110009325 Crystalline forms of rapamycin analogs |
| 01/13/2011 | US20110009323 Non-immunoglobulin antigen binding scaffolds for inhibiting angiogenesis and tumor growth |